rxLicense

License Required

wishlistAlt
Afluria® Quadrivalent 2023 - 2024 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Older Multiple-Dose Vial 5 mL
Afluria® Quadrivalent 2023 - 2024 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Older Multiple-Dose Vial 5 mL
Compare
View Alternative

Afluria® Quadrivalent 2023 - 2024 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Older Multiple-Dose Vial 5 mL

33332042310 | USAMP#70050571

container type

Multiple-Dose Vial
Prefilled Syringe

volume

5 mL
0.5 mL

dosage form

Injection

strength

60 mcg / 0.5 mL

Product Description

  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 6 Months and older
  • The multi-dose presentation contains thimerosal added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury

Product Specification

Manufacturer SKU

33332042310

NDC Code

33332042310

Manufacturer

Seqirus USA Inc

Brand

Afluria® Quadrivalent 2023 - 2024

USAMP SKU

USAMP#70050571

Application

Flu Vaccine

UNSPSC Code

51201608

Country Of Origin

Unknown

Storage Requirements

Requires Refrigeration

User

Indicated for People 6 Months of Age and Older

Volume

5 mL

Strength

60 mcg / 0.5 mL

Container Type

Multiple-Dose Vial

Type

Intramuscular

Dosage Form

Injection

Generic Drug Code

53937

Generic Drug Name

Influenza Virus Vaccine, Quadrivalent Inactivated